A landmark study published in Nature Cancer reveals striking new data on the speed and accuracy of artificial intelligence in brain tumor diagnosis. Researchers developed an AI system capable of classifying over 100 molecular subtypes of central nervous system tumors in approximately five minutes—compared to the current standard of 2-6 weeks for traditional molecular testing.
Validated across 2,334 tumor samples from multiple German centers, the system achieved a 95% diagnostic accuracy rate while analyzing standard H&E stained tissue sections. This represents a dramatic acceleration in pathology workflow without compromising diagnostic precision. The AI technology, developed by Prof. Stefan Pfister’s team at DKFZ, operates using microscopic imaging analysis available in conventional pathology labs, making it immediately implementable in diverse healthcare settings. Such rapid turnaround times could enable surgeons to make informed decisions during procedures, fundamentally changing the timeline for brain tumor patient care globally.
Read the full article on GMJ Newsroom.
Was this article helpful?
